000			01904nam a2200409 i 4500
999			_c268594 _d268594
001			on1015373866
003			BD
005			20180227124719.0
008			171215s2017 dcu l f000 0 eng c
040			_aPUCPR _beng _erda _cGPO _dMvI
042			_apcc
043			_an-us---
049			_aBDCG
050			_aKF50 _b.U56
074			_a0575
086	0		_aAE 2.110:115-52
088			_aPublic Law 115-52
099			_aAE 2.110:115-52
110	1		_aUnited States, _eenacting jurisdiction.
240	1	0	_aFDA Reauthorization Act of 2017
245	1	3	_aAn Act to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes.
264		1	_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c2017.
300			_a[86] pages ; _c24 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
500			_aShipping list no.: 2018-0084-P.
500			_a"Aug. 18, 2017 (H.R. 2430)."
500			_a"131 Stat. 1005."
500			_a"Public Law 115-52."
500			_aCRDP Program record.
650		0	_aDrugs _xPrices _xLaw and legislation _zUnited States.
650		0	_aPrescription pricing _xLaw and legislation _zUnited States.
650		0	_aMedical instruments and apparatus industry _xLaw and legislation _zUnited States.
650		0	_aGeneric drugs _xPrices _zUnited States.
650		0	_aBiologicals _xLaw and legislation _zUnited States.
650		0	_aUser charges _xLaw and legislation _zUnited States.
655		7	_aStatutes and codes. _2lcgft
776	0	8	_iOnline version: _aUnited States. _sFDA Reauthorization Act of 2017. _tAct to Amend the Federal Food, Drug, and Cosmetic Act to Revise and Extend the User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products, and for Other Purposes _w(OCoLC)1015373781
942			_2lcc _c15